loading

Myriad Genetics Inc Borsa (MYGN) Ultime notizie

pulisher
Nov 22, 2024

Natixis Advisors LLC Acquires 44,646 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN) - MarketBeat

Nov 22, 2024
pulisher
Nov 22, 2024

Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.

Nov 22, 2024
pulisher
Nov 21, 2024

Clinical Oncology Next Generation Sequencing (NGS) Market - openPR

Nov 21, 2024
pulisher
Nov 20, 2024

Myriad Genetics Announces Incorporation of its Proprietary - GlobeNewswire

Nov 20, 2024
pulisher
Nov 20, 2024

Myriad Genetics Expands Illumina Partnership, Integrates Key Cancer Testing Technology | MYGN Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

MYGN Stock Might Gain From SneakPeek Availability in Retail Stores - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Myriad Genetics (NASDAQ:MYGN) Downgraded to "Hold" Rating by StockNews.com - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

MYGN Beats on Q3 Earnings and Revenues, Raises '24 EPS View - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Breast Cancer Screening and Diagnostic Techniques Market - openPR

Nov 20, 2024
pulisher
Nov 19, 2024

Myriad Genetics (NASDAQ:MYGN) Reaches New 1-Year Low After Analyst Downgrade - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy - GlobeNewswire

Nov 19, 2024
pulisher
Nov 19, 2024

Myriad Genetics Launches Industry's First 8-Week Prenatal DNA Screen | MYGN Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 19, 2024

Myriad Genetics price target lowered to $21 from $32 at Morgan Stanley - Yahoo Finance

Nov 19, 2024
pulisher
Nov 18, 2024

Morgan Stanley Has Lowered Expectations for Myriad Genetics (NASDAQ:MYGN) Stock Price - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

State of New Jersey Common Pension Fund D Acquires New Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN) - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire

Nov 17, 2024
pulisher
Nov 15, 2024

Simplify Asset Management Inc. Buys Shares of 173,626 Myriad Genetics, Inc. (NASDAQ:MYGN) - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Predictive Genetic Testing & Consumer/Wellness Genomics - GlobeNewswire

Nov 14, 2024
pulisher
Nov 13, 2024

Long Term Trading Analysis for (MYGN) - Stock Traders Daily

Nov 13, 2024
pulisher
Nov 13, 2024

Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Minimal Residual Disease Testing Market Share, Growth Drivers, - openPR

Nov 13, 2024
pulisher
Nov 13, 2024

Myriad Genetics, Inc. (NASDAQ:MYGN) Just Reported Earnings, And Analysts Cut Their Target Price - Simply Wall St

Nov 13, 2024
pulisher
Nov 13, 2024

Myriad Genetics stock hits 52-week low at $16.6 amid market shifts - Investing.com Australia

Nov 13, 2024
pulisher
Nov 12, 2024

Myriad Genetics Inc (MYGN) Shares Gap Down to $16.76 on Nov 12 - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Myriad Genetics: Healthcare Marketing Impact Awards 2024 - Modern Healthcare

Nov 12, 2024
pulisher
Nov 12, 2024

How Myriad Genetics helped address the gap in genetic testing among women - Ad Age

Nov 12, 2024
pulisher
Nov 11, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Investors to Learn More About the Investigation - AccessWire

Nov 11, 2024
pulisher
Nov 11, 2024

Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024
pulisher
Nov 11, 2024

Piper Sandler Has Lowered Expectations for Myriad Genetics (NASDAQ:MYGN) Stock Price - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

U.S. Women Health Laboratory Testing Market to Witness - openPR

Nov 11, 2024
pulisher
Nov 10, 2024

Myriad Genetics, Inc. (MYGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire

Nov 10, 2024
pulisher
Nov 09, 2024

Myriad Genetics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

Myriad Genetics Inc (MYGN) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

Myriad Genetics Inc (MYGN) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Myriad Genetics Inc (MYGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Policy ... - Yahoo Finance

Nov 08, 2024
pulisher
Nov 07, 2024

Myriad Genetics earnings beat by $0.04, revenue topped estimates - Investing.com Canada

Nov 07, 2024
pulisher
Nov 07, 2024

Myriad: Q3 Earnings Snapshot - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Myriad Genetics Inc Reports Q3 2024 Revenue of $213 Million, Bea - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Compared to Estimates, Myriad (MYGN) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Myriad Genetics (MYGN) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance - The Manila Times

Nov 07, 2024
pulisher
Nov 06, 2024

Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Investors to Inquire about Securities Investigation - AccessWire

Nov 06, 2024
pulisher
Nov 06, 2024

Pancreatic Cancer Market Expected to Reach $5.7 Billion by 2031 | - openPR

Nov 06, 2024
pulisher
Nov 06, 2024

MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm - PR Newswire

Nov 06, 2024
pulisher
Nov 06, 2024

BIIB vs. MYGN: Which Stock Is the Better Value Option? - Yahoo Finance

Nov 06, 2024
pulisher
Nov 05, 2024

MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announ - WICZ

Nov 05, 2024
pulisher
Nov 05, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Myriad Genetics, Inc. (MYGN) And Encourages Investors to Reach Out - AccessWire

Nov 05, 2024
pulisher
Nov 05, 2024

Cancer Diagnostics Market 2024-2031 Product Size Analysis: - openPR

Nov 05, 2024
pulisher
Nov 05, 2024

Myriad Genetics holds stock target after UNH update By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

UnitedHealthcare limits coverage for Myriad's GeneSight test By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 04, 2024

UnitedHealthcare limits coverage for Myriad's GeneSight test - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Myriad Genetics, Inc. (MYGN) And Encourages Stockholders to Reach Out - AccessWire

Nov 04, 2024
pulisher
Nov 04, 2024

Myriad Genetics (NASDAQ:MYGN) Shares Down 4.6%What's Next? - MarketBeat

Nov 04, 2024
diagnostics_research LH
$239.67
price down icon 0.21%
$167.26
price down icon 1.24%
diagnostics_research WAT
$373.47
price up icon 1.35%
$140.14
price up icon 2.30%
diagnostics_research MTD
$1,217.97
price up icon 1.77%
$417.24
price down icon 0.31%
Capitalizzazione:     |  Volume (24 ore):